Skip to main content
. 2013 Jul;84(1):86–94. doi: 10.1124/mol.113.085902

Fig. 1.

Fig. 1.

Chemical structures of the three generations of systemic azoles developed for use in humans. The structures and drug names in black and gray are of the marketed and experimental azoles, respectively. The numbering of some of the heteroatoms in clotrimazole, posaconazole, and voriconazole is also shown.